Standard
Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy. / Callreus, Torbjorn; Sessa, Maurizio; El-Galaly, Tarec; Jerkeman, Mats; Andersen, Morten.
2019. 190-190.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › fagfællebedømt
Harvard
Callreus, T
, Sessa, M, El-Galaly, T, Jerkeman, M
& Andersen, M 2019, '
Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy', s. 190-190.
https://doi.org/10.1002/pds.4732APA
Callreus, T.
, Sessa, M., El-Galaly, T., Jerkeman, M.
, & Andersen, M. (2019).
Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy. 190-190.
https://doi.org/10.1002/pds.4732Vancouver
Callreus T
, Sessa M, El-Galaly T, Jerkeman M
, Andersen M.
Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy. 2019.
https://doi.org/10.1002/pds.4732Author
Callreus, Torbjorn ; Sessa, Maurizio ; El-Galaly, Tarec ; Jerkeman, Mats ; Andersen, Morten. / Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy.
Bibtex
@conference{62f46b0eec184cb1bb003ed7dd3d2d79,
title = "Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy",
author = "Torbjorn Callreus and Maurizio Sessa and Tarec El-Galaly and Mats Jerkeman and Morten Andersen",
year = "2019",
doi = "10.1002/pds.4732",
language = "English",
pages = "190--190",
}
RIS
TY - ABST
T1 - Monitoring of medicinal products authorized based on a single-arm trial: The case of a CAR-T cell therapy
AU - Callreus, Torbjorn
AU - Sessa, Maurizio
AU - El-Galaly, Tarec
AU - Jerkeman, Mats
AU - Andersen, Morten
PY - 2019
Y1 - 2019
U2 - 10.1002/pds.4732
DO - 10.1002/pds.4732
M3 - Conference abstract for conference
C2 - 30740819
SP - 190
EP - 190
ER -
